RESUMO
Four new heterospin compounds with molecular formula {[Cu2(hfac)3(TlTrzNIT)2][Ln(hfac)4]} n·C7H16 (LnIII = Gd (1), Tb (2), or Dy (3)) and [Co(hfac)(TlTrzNIT)2][Dy(hfac)4] (4), where hfac is hexafluoroacetylacetonato and TlTrzNIT is the nitronylnitroxide radical 1-( m-tolyl)-1 H-1,2,3-triazole-4-(4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide), were obtained. All structures were determined by single-crystal X-ray diffraction. In compounds 1-3, the TlTrzNIT radical is bridge-coordinated to copper(II) ions, leading to positively charged copper(II)-radical chains containing [Ln(hfac)4]- as counterions. In compound 4, the cobalt(II) ion is coordinated to two TlTrzNIT radicals and one hfac ligand in bidentate mode leading to a mononuclear cationic complex that contains [Dy(hfac)4]- as counterion. Magnetic measurements of all complexes were performed. Magnetic data were fit considering the contributions of the copper(II)-radical chain and a paramagnetic gadolinium(III) ion for 1. The sign and magnitude of the magnetic coupling constants extracted from the fit were confirmed by density functional theory calculations. The obtained spin topology shows an alternated ferro-antiferromagnetic chain. Field-induced single molecule magnet behavior was observed for the Dy derivatives 3 and 4, in agreement with CASSCF calculations performed for the latter system.
RESUMO
BACKGROUND: Low molecular weight 1,2,3-triazoles and naphthoquinones are endowed with various types of biological activity, such as against cancer, HIV and bacteria. However, in some cases, the conjugation of these two nuclei considerably increases their biological activities. OBJECTIVE: In this work, we decided to study the synthesis and screening of bis-naphthoquinones and xanthenes tethered to 1,2,3-triazoles against cancer cell lines, specifically the human breast cancer cell line MCF-7. RESULTS: Starting from lawsone and aryl-1H-1,2,3-triazole-4-carbaldehydes (10a-h) several new 7- (1-aryl-1H-1,2,3-triazol-4-yl)-6H-dibenzo[b,h]xanthene-5,6,8,13(7H)-tetraones (12a-h) and 3,3'- ((1-aryl-1H-1,2,3-triazol-4-yl)methylene)bis(2-hydroxynaphthalene-1,4-diones) 11a-h were synthesized and evaluated for their cytotoxic activities using the human breast cancer cell line MCF-7 and the non-tumor cell line MCF10A as control. We performed test of cell viability, cell proliferation, intracellular ATP content and cell cytometry to determine reactive oxygen species (ROS) formation. CONCLUSIONS: Based on these results, we found that compound 12a promotes ROS production, interfering with energy metabolism, cell viability and proliferation, and thus promoting whole cell damage.